References
- QiSFZhangBWangHJPrevalence of hypertension subtypes in 2011 and the trends from 1991 to 2011 among Chinese adultsJ Epidemiol Community Health201670544445126612877
- WangJZhangLWangFLiuLWangHPrevalence, awareness, treatment, and control of hypertension in China: results from a national surveyAm J Hypertens201427111355136124698853
- BlacherJAsmarRDjaneSLondonGMSafarMEAortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patientsHypertension19993351111111710334796
- CeceljaMChowienczykPRole of arterial stiffness in cardiovascular diseaseJRSM Cardiovasc Dis201214
- JanicMLunderMSabovicMArterial stiffness and cardiovascular therapyBiomed Res Int2014201462143725170513
- DuprezDAIs vascular stiffness a target for therapy?Cardiovasc Drugs Ther201024430531020628896
- BrownMJPalmerCRCastaigneAMorbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)Lancet2000356922736637210972368
- Poole-WilsonPALubsenJKirwanBAEffect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trialLancet2004364943784985715351192
- HasebeNKikuchiKControlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) studyJ Hypertens200523244545315662234
- SaitoIFujikawaKSarutaTCost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) studyHypertens Res20083171399140518957811
- FukudaMMasudaTOguraMNInfluence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patientsHypertens Res200932539239819373239
- VajaVOchodnickyPKrenekPKlimasJBajuszovaZKyselovicJRapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive ratsEur J Pharmacol20096191–3859119683522
- KitaTSuzukiYEtoTKitamuraKLong-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure loweringHypertens Res2005281295996416671334
- DudenbostelTGlasserSPEffects of antihypertensive drugs on arterial stiffnessCardiol Rev201220525926322573107
- GlasserSPDudenbostelTThe global burden of cardiovascular disease: the role of endothelial function and arterial elasticity in cardiovascular disease as novel and emerging biomarkersCurr Cardiovasc Risk Rep20115218719524000308
- PayneRAWilkinsonIBWebbDJArterial stiffness and hypertension: emerging conceptsHypertension201055191419948990
- NajjarSSScuteriAShettyVPulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore longitudinal study of agingJ Am Coll Cardiol200851141377138318387440
- CohnJNFinkelsteinSMcVeighGNoninvasive pulse wave analysis for the early detection of vascular diseaseHypertension19952635035087649589
- ZiemanSJMelenovskyVKassDAMechanisms, pathophysiology, and therapy of arterial stiffnessArterioscler Thromb Vasc Biol200525593294315731494
- TomiyamaHKushiroTOkazakiRYoshidaHDobaNYamashinaAInfluences of increased oxidative stress on endothelial function, platelets function, and fibrinolysis in hypertension associated with glucose intoleranceHypertens Res200326429530012733697
- SethiSRiveraOOliverosRChiltonRAortic stiffness: pathophysiology, clinical implications, and approach to treatmentIntegr Blood Press Control20147293424910511
- WentlandALGristTMWiebenOReview of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffnessCardiovasc Diagn Ther20144219320624834415
- ProtogerouADStergiouGSVlachopoulosCBlacherJAchimastosAThe effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: evidence for specific class-effects of antihypertensive drugs on pressure amplificationCurr Pharm Des200915327228919149618
- ShahinYKhanJAChetterIAngiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trialsAtherosclerosis20122211183322209214
- AgnolettiDZhangYBorghiCBlacherJSafarMEEffects of anti-hypertensive drugs on central blood pressure in humans: a preliminary observationAm J Hypertens20132681045105223736112
- HayozDZappeDHMeyerMAChanges in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimenJ Clin Hypertens (Greenwich)2012141177377823126349
- BoesbyLElung-JensenTStrandgaardSKamperALEplerenone attenuates pulse wave reflection in chronic kidney disease stage 3–4 – a randomized controlled studyPLoS One201385e6454923704994
- VizzardiEPinaPDCarettaGThe effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathyJ Cardiovasc Med (Hagerstown)201516959760224978872
- PoloniaJBarbosaLSilvaJABertoquiniSDifferent patterns of peripheral versus central blood pressure in hypertensive patients treated with beta-blockers either with or without vasodilator properties or with angiotensin receptor blockersBlood Press Monit201015523523920577082
- ElliottHLElawadMWilkinsonRSinghSPPersistence of anti-hypertensive efficacy after missed doses: comparison of amlodipine and nifedipine gastrointestinal therapeutic systemJ Hypertens200220233333811821720
- HeagertyAMNifedipine gastrointestinal therapeutic system – hypertension management to improve cardiovascular outcomesInt J Clin Pract20055991112111916115193
- LeeSJBellDACoulterSJGhanayemBGoldsteinJARecombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotypeJ Pharmacol Exp Ther2005313130230915634941
- HsiehKPLinYYChengCLNovel mutations of CYP3A4 in ChineseDrug Metab Dispos200129326827311181494
- GuoCPeiQITanHHuangZYuanHYangGEffects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patientsBiomed Rep20153219520026075072
- LubsenJWagenerGKirwanBAdeBSPoole-WilsonPAEffect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trialJ Hypertens200523364164815716708
- NissenSETuzcuEMLibbyPEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA2004292182217222515536108
- MunakataMNagasakiANunokawaTEffects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patientsAm J Hypertens20041711 Pt 11050105515533733